These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 20559428)
1. Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures. Pulford B; Reim N; Bell A; Veatch J; Forster G; Bender H; Meyerett C; Hafeman S; Michel B; Johnson T; Wyckoff AC; Miele G; Julius C; Kranich J; Schenkel A; Dow S; Zabel MD PLoS One; 2010 Jun; 5(6):e11085. PubMed ID: 20559428 [TBL] [Abstract][Full Text] [Related]
2. Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes. Bender HR; Kane S; Zabel MD J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501362 [TBL] [Abstract][Full Text] [Related]
3. Lipopeptide Delivery of siRNA to the Central Nervous System. Zabel MD; Mollnow L; Bender H Methods Mol Biol; 2019; 1943():389-403. PubMed ID: 30838631 [TBL] [Abstract][Full Text] [Related]
4. Lipopeptide delivery of siRNA to the central nervous system. Zabel MD Methods Mol Biol; 2013; 948():251-62. PubMed ID: 23070775 [TBL] [Abstract][Full Text] [Related]
5. siRNA Therapeutics for Protein Misfolding Diseases of the Central Nervous System. Zabel MD; Mollnow L; Bender H Methods Mol Biol; 2021; 2282():377-394. PubMed ID: 33928585 [TBL] [Abstract][Full Text] [Related]
6. PrPC knockdown by liposome-siRNA-peptide complexes (LSPCs) prolongs survival and normal behavior of prion-infected mice immunotolerant to treatment. Bender H; Noyes N; Annis JL; Hitpas A; Mollnow L; Croak K; Kane S; Wagner K; Dow S; Zabel M PLoS One; 2019; 14(7):e0219995. PubMed ID: 31329627 [TBL] [Abstract][Full Text] [Related]
7. Transvascular delivery of small interfering RNA to the central nervous system. Kumar P; Wu H; McBride JL; Jung KE; Kim MH; Davidson BL; Lee SK; Shankar P; Manjunath N Nature; 2007 Jul; 448(7149):39-43. PubMed ID: 17572664 [TBL] [Abstract][Full Text] [Related]
8. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. Vincent B; Paitel E; Frobert Y; Lehmann S; Grassi J; Checler F J Biol Chem; 2000 Nov; 275(45):35612-6. PubMed ID: 10952979 [TBL] [Abstract][Full Text] [Related]
9. An overlapping reading frame in the PRNP gene encodes a novel polypeptide distinct from the prion protein. Vanderperre B; Staskevicius AB; Tremblay G; McCoy M; O'Neill MA; Cashman NR; Roucou X FASEB J; 2011 Jul; 25(7):2373-86. PubMed ID: 21478263 [TBL] [Abstract][Full Text] [Related]
10. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion. Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147 [TBL] [Abstract][Full Text] [Related]
11. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity. Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911 [TBL] [Abstract][Full Text] [Related]
12. Prion infection of mouse neurospheres. Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413 [TBL] [Abstract][Full Text] [Related]
13. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes. Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of prion protein (PrP) by RNA interference weakens the protective activity of wild-type PrP against copper ion and antagonizes the cytotoxicity of fCJD-associated PrP mutants in cultured cells. Wang ZY; Tian C; Jing YY; Gong HS; Guo Y; Shi Q; Chen C; Zhu SY; Dong XP Int J Mol Med; 2011 Sep; 28(3):413-21. PubMed ID: 21537833 [TBL] [Abstract][Full Text] [Related]
15. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras. Kupfer L; Eiden M; Buschmann A; Groschup MH Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171 [TBL] [Abstract][Full Text] [Related]
16. Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells. Hamanaka T; Nishizawa K; Sakasegawa Y; Oguma A; Teruya K; Kurahashi H; Hara H; Sakaguchi S; Doh-Ura K J Virol; 2017 Mar; 91(6):. PubMed ID: 28077650 [TBL] [Abstract][Full Text] [Related]
17. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1. Allard EK; Grujic M; Fisone G; Kristensson K Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760 [TBL] [Abstract][Full Text] [Related]
18. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Cronier S; Laude H; Peyrin JM Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929 [TBL] [Abstract][Full Text] [Related]
19. Prions of ruminants show distinct splenotropisms in an ovine transgenic mouse model. Baron T; Bencsik A; Morignat E PLoS One; 2010 Apr; 5(4):e10310. PubMed ID: 20436680 [TBL] [Abstract][Full Text] [Related]
20. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations. Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]